国药一心制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
73
NMPA:73
Drug Approvals
Trifluridine and Tipiracil Hydrochloride Tablets
- Product Name
- 曲氟尿苷替匹嘧啶片
- Approval Number
- 国药准字H20253941
- Approval Date
- Apr 15, 2025
NMPA
Trifluridine and Tipiracil Hydrochloride Tablets
- Product Name
- 曲氟尿苷替匹嘧啶片
- Approval Number
- 国药准字H20253942
- Approval Date
- Apr 15, 2025
NMPA
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20247196
- Approval Date
- Aug 22, 2024
NMPA
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20247195
- Approval Date
- Aug 22, 2024
NMPA
Octreotide Acetate Injection
- Product Name
- 醋酸奥曲肽注射液
- Approval Number
- 国药准字H20247173
- Approval Date
- Jul 23, 2024
NMPA
Cytarabine for Injection
- Product Name
- 注射用阿糖胞苷
- Approval Number
- 国药准字H20223921
- Approval Date
- Dec 20, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found